Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome

Abstract

Rituximab is an effective treatment option in the short- and long-term control of treatment refractory SSNS. Further controlled studies are needed to address optimal patient selection, dose and safety of rituximab infusions.